Romiplostim Market to Reach USD 2.75 Billion by 2034 Amid Rising Demand for Advanced Immune Thrombocytopenia Treatments
According to a report by Intel Market Research, the global Romiplostim market was valued at USD 1.45 billion in 2025 and is projected to grow from USD 1.58 billion in 2026 to USD 2.75 billion by 2034, registering a CAGR of 7.2% during the forecast period. The market is witnessing steady expansion driven by the increasing prevalence of chronic immune thrombocytopenia (ITP), growing adoption of...
0 التعليقات 0 المشاركات 19 مشاهدة 0 معاينة